Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mitsuhiro Seki is active.

Publication


Featured researches published by Mitsuhiro Seki.


Cancer Science | 2007

DNA methylation of the RIZ1 gene is associated with nuclear accumulation of p53 in prostate cancer

Yasuhisa Hasegawa; Akio Matsubara; Jun Teishima; Mitsuhiro Seki; Koji Mita; Tsuguru Usui; Naohide Oue; Wataru Yasui

The retinoblastoma protein‐interacting zinc finger gene, RIZ1, is thought to be a tumor suppressor gene. RIZ1 is inactivated by mutation, deletion and DNA methylation in several human cancers. In the present study, the relationship between DNA methylation of RIZ1 and mutation of p53 was investigated in prostate cancer (PCa). In total, 47 cases of node‐negative PCa (stages I–III) were analyzed. DNA methylation of the RIZ1 gene was detected in 20 (42.6%) of the 47 PCa tissues by methylation‐specific polymerase chain reaction. DNA methylation of the RIZ1 gene was not associated with clinicopathological features. DNA methylation of RIZ1 tended to be present more frequently in PCa specimens with a high Gleason score (16/30, 53.3%) than in those with a low Gleason score (4/17, 23.5%); however, this tendency was not statistically significant (P = 0.0675). Nuclear accumulation of p53 was observed in four (8.5%) of 47 PCa specimens by immunostaining. All four PCa specimens with nuclear accumulation of p53 were stage III disease and showed DNA methylation of RIZ1. However, of the remaining 43 cancers without nuclear accumulation of p53, DNA methylation of RIZ1 was observed in only 16 (37.2%) specimens (P = 0.0272). Of the three PCa cell lines, only the PC3 cell line showed loss of RIZ1 mRNA due to DNA methylation, and this loss was rectified by treatment with a demethylating agent, 5‐Aza‐2′‐deoxycytidine. These results suggest that transcriptional inactivation of RIZ1 by aberrant DNA methylation may contribute to prostate carcinogenesis. Genetic alterations are likely associated with epigenetic alterations in PCa. (Cancer Sci 2007; 98: 32–36)


International Journal of Urology | 2006

Lower urinary tract symptoms and risk of prostate cancer in Japanese men

Akio Matsubara; Hiroaki Yasumoto; Jun Teishima; Mitsuhiro Seki; Koji Mita; Yasuhisa Hasegawa; Tateki Yoshino; Masao Kato; Tsuguru Usui

Aim: Our aim was to investigate whether or not men with lower urinary tract symptoms are at increased risk of prostate cancer.


International Journal of Urology | 2005

Impact of radical perineal prostatectomy on urinary continence and quality of life: A longitudinal study of Japanese patients

Akio Matsubara; Hiroaki Yasumoto; Kazuaki Mutaguchi; Koji Mita; Jun Teishima; Mitsuhiro Seki; Mitsuru Kajiwara; Masao Kato; Masanobu Shigeta; Tsuguru Usui

Aim: We used self‐completed questionnaires to obtain a longitudinal assessment of urinary continence and urinary, bowel, and sexual domain‐related quality of life (QOL) in Japanese patients undergoing radical perineal prostatectomy (RPP).


European Urology | 2005

Urological Retroperitoneoscopic Surgery for Patients with Prior Intra-Abdominal Surgery

Koji Mita; Masanobu Shigeta; Kazuaki Mutaguchi; Akio Matsubara; Tateki Yoshino; Mitsuhiro Seki; Hideki Mochizuki; Masao Kato; Jun Teishima; Yuichi Kadonishi; Hiroaki Yasumoto; Tsuguru Usui


Maturitas | 2007

Women's perception of male erectile dysfunction drugs in the general population

Koji Mita; Masanobu Shigeta; Masayuki Kakehashi; Akio Matsubara; Jun Teishima; Masao Kato; Mitsuhiro Seki; Yasuhisa Hasegawa; Yoji Inoue; Tsuguru Usui


Anticancer Research | 2008

Restoration of FGF Receptor Type 2 Enhances Radiosensitivity of Hormone-refractory Human Prostate Carcinoma PC-3 Cells

Akio Matsubara; Jun Teishima; Suichinov Mirkhat; Hiroaki Yasumoto; Hideki Mochizuki; Mitsuhiro Seki; Kazuaki Mutaguchi; Wallace L. McKeehan; Tsuguru Usui


Hiroshima journal of medical sciences | 2013

Restoration of IGFBP-rP1 Increases Radiosensitivity and Chemosensitivity in Hormone-refractory Human Prostate Cancer

Mitsuhiro Seki; Jun Teishima; Hideki Mochizuki; Kazuaki Mutaguchi; Hiroaki Yasumoto; Kiyotaka Oka; Hirotaka Nagamatsu; Koichi Shoji; Akio Matsubara


Hiroshima journal of medical sciences | 2006

Transrectal Ultrasound-guided 10-core Biopsy of the Prostate for Japanese Patients

Akio Matsubara; Kazuaki Mutaguchi; Hiroaki Yasumoto; Yukio Takeshima; Jun Teishima; Mitsuhiro Seki; Yasuhiro Hasegawa; Tsuguru Usui


Nishinihon Journal of Urology | 2009

Alternation of non-steroidal antiandrogens for progressive prostate cancer following maximum androgen blockade - Results of non-steroidal antiandrogen sequential alternation for prostate cancer (NASA-PC) study group

Naohiro Fujimoto; Tetsuro Matsumoto; Hiroyoshi Suzuki; Tomohiko Ichikawa; Koji Okihara; Tsuneharu Miki; Hideaki Miyake; Masato Fujisawa; Motohide Uemura; Susumu Miyoshi; Takatoshi Tacho; Akira Yano; Motohiro Fujii; Yoshio Takihana; Masayuki Takeda; Mitsuhiro Seki; Akio Matsubara; Tsuguru Usui; Hidefumi Kinoshita; Soichi Mugiya; Seiichiro Ohzono; Yasutomo Nasu; Takashi Saika; Hiromi Kumon


Hiroshima journal of medical sciences | 2006

Nonfunctional Pituitary Macroadenoma Manifested as Muscular Symptoms

Akio Matsubara; Aki Tamura; Syunji Matsumura; Hitoshi Yokoya; Satoshi Maruyama; Kanao Kobayashi; Yukihiko Kawamoto; Jun Teishima; Mitsuhiro Seki; Tsuguru Usui

Collaboration


Dive into the Mitsuhiro Seki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge